Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa

Key facts

Sponsor

CF Therapeutics Development Network Coordinating Center

Principal Investigator

Lisa Saiman, MD, MPH

Columbia University

Intervention

azithromycin 250 mg tablets(drug)

Enrollment

263 enrolled

Eligibility

6-18 years · All sexes

Timeline

2007 – 2009

Study locations (30)

• Phoenix Children's Hospital, Phoenix, Arizona, United States
• Connecticut Children's Medical Center, Hartford, Connecticut, United States
• Emory University, Atlanta, Georgia, United States
• Children's Memorial Hospital, Chicago, Illinois, United States
• Riley Hospital for Children, Indianapolis, Indiana, United States
• University of Kentucky, Lexington, Kentucky, United States
• Children's Hospital Boston, Boston, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• University of Minnesota, Minneapolis, Minnesota, United States
• Children's Mercy Hospital, Kansas City, Missouri, United States
• Washington University, St Louis, Missouri, United States
• University of Nebraska Medical Center - Pediatric Pulmonary, Omaha, Nebraska, United States
• Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
• Columbia University, New York, New York, United States
• University of Rochester Medical Center, Rochester, New York, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

Cystic Fibrosis Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Genetic digestive tract malformation

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT06507956
  Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
  Hospices Civils de Lyon
• RECRUITINGNCT06296394
  Health Outcomes of Parents With Cystic Fibrosis-Aim 2
  University of Pittsburgh
• RECRUITINGPHASE1NCT06154447
  Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
  Vertex Pharmaceuticals Incorporated
• RECRUITINGNCT06191640
  Sinus Disease in Young Children With Cystic Fibrosis
  University of California, Los Angeles
• RECRUITINGNCT05501587
  Measures of Respiratory Health Registry
  University of British Columbia

See all trials for Genetic digestive tract malformation →